The Transcriptomic Landscape of Prostate Cancer Development and Progression: An Integrative Analysis

被引:6
|
作者
Marzec, Jacek [1 ]
Ross-Adams, Helen [1 ]
Pirro, Stefano [1 ]
Wang, Jun [1 ]
Zhu, Yanan [2 ]
Mao, Xueying [2 ]
Gadaleta, Emanuela [1 ]
Ahmad, Amar S. [3 ]
North, Bernard V. [3 ]
Kammerer-Jacquet, Solene-Florence [2 ]
Stankiewicz, Elzbieta [2 ]
Kudahetti, Sakunthala C. [2 ]
Beltran, Luis [4 ]
Ren, Guoping [5 ]
Berney, Daniel M. [2 ,4 ]
Lu, Yong-Jie [2 ]
Chelala, Claude [1 ,6 ]
机构
[1] Queen Mary Univ London, Barts Canc Inst, Bioinformat Unit, Ctr Canc Biomarkers & Biotherapeut, London EC1M 6BQ, England
[2] Queen Mary Univ London, Barts Canc Inst, Ctr Canc Biomarkers & Biotherapeut, London EC1M 6BQ, England
[3] Queen Mary Univ London, Wolfson Inst Prevent Med, Barts & London Sch Med, Ctr Canc Prevent, London EC1M 6BQ, England
[4] Barts Hlth NHS, Dept Pathol, London E1 F1R, England
[5] Zhejiang Univ, Med Coll, Dept Pathol, Affiliated Hosp 1, Hangzhou 310058, Peoples R China
[6] Queen Mary Univ London, Life Sci Initiat, Ctr Computat Biol, London EC1M 6BQ, England
基金
英国工程与自然科学研究理事会;
关键词
prostate cancer; tumorigenesis; mRNA; RNAseq; transcriptomic; data integration;
D O I
10.3390/cancers13020345
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary There is a tremendous amount of gene expression information available for prostate cancer, but very few tools exist to combine the disparate datasets generated across sample types and technical platforms. We present a method of integrating different types of expression data from different study cohorts to increase analytic power, and improve our understanding of the molecular changes underlying the development and progression of prostate cancer from normal to advanced disease. Using this approach, we identified nine additional disease stage-specific candidate genes with prognostic significance, which were not identified in any one study alone. We have developed a free online tool summarizing our results, and making the complete combined dataset available for further translational research. Next-generation sequencing of primary tumors is now standard for transcriptomic studies, but microarray-based data still constitute the majority of available information on other clinically valuable samples, including archive material. Using prostate cancer (PC) as a model, we developed a robust analytical framework to integrate data across different technical platforms and disease subtypes to connect distinct disease stages and reveal potentially relevant genes not identifiable from single studies alone. We reconstructed the molecular profile of PC to yield the first comprehensive insight into its development, by tracking changes in mRNA levels from normal prostate to high-grade prostatic intraepithelial neoplasia, and metastatic disease. A total of nine previously unreported stage-specific candidate genes with prognostic significance were also found. Here, we integrate gene expression data from disparate sample types, disease stages and technical platforms into one coherent whole, to give a global view of the expression changes associated with the development and progression of PC from normal tissue through to metastatic disease. Summary and individual data are available online at the Prostate Integrative Expression Database (PIXdb), a user-friendly interface designed for clinicians and laboratory researchers to facilitate translational research.
引用
收藏
页码:1 / 24
页数:25
相关论文
共 50 条
  • [41] The integrative metabolomic-transcriptomic landscape of glioblastome multiforme
    Heiland, Dieter Henrik
    Woerner, Jakob
    Haaker, Jan Gerrit
    Delev, Daniel
    Pompe, Nils
    Mercas, Bianca
    Franco, Pamela
    Gabelein, Annette
    Heynckes, Sabrina
    Pfeifer, Dietmar
    Weber, Stefan
    Mader, Irina
    Schnell, Oliver
    ONCOTARGET, 2017, 8 (30) : 49178 - 49190
  • [42] Landscape of Chromosome Number Changes during Prostate Cancer Progression
    Stomper, J.
    Braun, M.
    Vogel, W.
    Boehm, D.
    Scheble, V.
    Fend, F.
    Perner, S.
    LABORATORY INVESTIGATION, 2012, 92 : 242A - 243A
  • [43] Landscape of Chromosome Number Changes during Prostate Cancer Progression
    Stomper, J.
    Braun, M.
    Vogel, W.
    Boehm, D.
    Scheble, V.
    Fend, F.
    Perner, S.
    MODERN PATHOLOGY, 2012, 25 : 242A - 243A
  • [44] Decoding the heterogeneous landscape in the development prostate cancer
    Segura-Moreno, Yenifer Yamile
    Sanabria-Salas, Maria Carolina
    Varela, Rodolfo
    Mesa, Jorge Andres
    Serrano, Martha Lucia
    ONCOLOGY LETTERS, 2021, 21 (05)
  • [45] Development and Verification of a Prostate Cancer Prognostic Signature Based on an Immunogenomic Landscape Analysis
    Cheng, Hong
    Wang, Yi
    Liu, Chunhui
    Wu, Tiange
    Chen, Shuqiu
    Chen, Ming
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [46] The role of PPARγ in prostate cancer development and progression
    Andrew Hartley
    Imran Ahmad
    British Journal of Cancer, 2023, 128 : 940 - 945
  • [47] Role of diet in prostate cancer development and progression
    Chan, JM
    Gann, PH
    Giovannucci, EL
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (32) : 8152 - 8160
  • [48] The role of PPAR? in prostate cancer development and progression
    Hartley, Andrew
    Ahmad, Imran
    BRITISH JOURNAL OF CANCER, 2023, 128 (06) : 940 - 945
  • [49] The role of cyclins in the development and progression of prostate cancer
    Dulinska-Litewka, Joanna
    Felkle, Dominik
    Dykas, Kacper
    Handziuk, Zuzanna
    Krzysztofik, Marta
    Gasiorkiewicz, Bartosz
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 155
  • [50] The role of glycans in the development and progression of prostate cancer
    Munkley, Jennifer
    Mills, Ian G.
    Elliott, David J.
    NATURE REVIEWS UROLOGY, 2016, 13 (06) : 324 - 333